Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT - Additional Information (Details)

v3.24.3
SHAREHOLDERS' DEFICIT - Additional Information (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 09, 2024
item
$ / shares
shares
Jul. 08, 2024
item
$ / shares
shares
Jun. 27, 2024
USD ($)
shares
Jun. 21, 2024
Aug. 16, 2023
Mar. 04, 2023
item
$ / shares
shares
Jul. 31, 2024
Mar. 31, 2024
USD ($)
EquityInstruments
shares
Aug. 31, 2023
$ / shares
shares
Jun. 30, 2023
shares
May 31, 2023
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jul. 07, 2024
$ / shares
shares
May 14, 2024
shares
Apr. 08, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
$ / shares
shares
Mar. 03, 2023
$ / shares
shares
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Common stock, shares authorized   13,888,888       9,000,000             13,888,888   13,888,888     250,000,000   500,000 180,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.001       $ 0.001             $ 0.001   $ 0.001   $ 0.001     $ 0.001 $ 0.001
Common stock, shares issued                         605,024   605,024         373,359  
Common stock, shares outstanding                         605,024   605,024         373,359  
Holders of number of shares of common stock present and approved for increase of authorized shares                                   5,427,462      
Period to submit plan to regain compliance         45 days                                
Price per share | $ / shares                     $ 21.60                    
Stock-based compensation (in shares)               14,931                          
Dividend factor applied to common stock issuable, to effect reverse stock split | item           20                              
Multiplication factor applied to exercise price or conversion price, to effect reverse stock split | item           20                              
Accounts payable settled in common shares | $     $ 437,000                                    
Accounts payable settled in common shares | $                         $ 437,000   $ 437,000            
Accounts payable settled in common shares (in shares)     104,468                                    
Underwritten public offering, number of shares                     277,778                    
Common shares to certain employees, directors and vendors in lieu of cash compensation                   3,319                      
Reverse stock split ratio           0.05           0.05                  
Gross proceeds | $                           $ 5,083,000   $ 5,383,000          
Innovation Neuromonitoring LLC                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Exchange price per share | $ / shares                                     $ 11.12    
Subscription of shares                                     24,292    
Cancellation of future installment payments | $                                     $ 270,000    
Convertible Debt                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Common shares issued to settle amounts owed | EquityInstruments               74,298                          
Debt repaid | $               $ 334,000                          
Debt Instrument, Convertible, Settlement Method [Extensible Enumeration]               us-gaap:ShareSettlementMember                          
Reverse stock split ratio       0.05556                                  
Subsequent Events                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Common stock, shares authorized 13,888,888 13,888,888                             250,000,000        
Common stock, par value (in dollars per share) | $ / shares $ 0.001 $ 0.001                                      
Dividend factor applied to common stock issuable, to effect reverse stock split | item 18 18                                      
Multiplication factor applied to exercise price or conversion price, to effect reverse stock split | item 18 18                                      
Reverse stock split ratio 0.0556 0.05556         0.0556                            
Fractional shares issued 0 0                                      
Amended Stock Option Plan                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Common stock, shares outstanding                         800   800            
Equity Incentive Plan                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Common stock, shares outstanding                         0   0            
Number of shares authorized                         100,000   100,000            
Private Placements                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Shares issued                       2,778                  
Gross proceeds | $                       $ 300,000                  
Shares issue price | $ / shares                       $ 108.00                  
Public offering (pre-funded warrants)                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Price per share | $ / shares                     $ 21.58                    
Pre-funded warrants                     750,000                    
Pre-funded warrants, shares                 750,000                        
Warrant exercise price (in dollars per share) | $ / shares                 $ 0.001                        
Gross proceeds | $                     $ 6,000,000                    
Option to purchase additional shares                                          
SHAREHOLDERS' EQUITY (DEFICIT)                                          
Number of days to purchase additional shares                     45 days                    
Underwritten public offering, number of shares                     41,667